Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review) | Zendy

Konstantinos Christofyllakis | Zendy; Joerg Thomas Bittenbring | Zendy; Lorenz Thurner | Zendy; Manfred Ahlgrimm | Zendy; Stephan Stilgenbauer | Zendy; Moritz Bewarder | Zendy; Dominic KadduMulindwa | Zendy

Open Access

Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review)

Author(s) -

Konstantinos Christofyllakis,

Joerg Thomas Bittenbring,

Lorenz Thurner,

Manfred Ahlgrimm,

Stephan Stilgenbauer,

Moritz Bewarder,

Dominic KadduMulindwa

Publication year - 2021

Publication title -

molecular and clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.442

H-Index - 7

eISSN - 2049-9469

pISSN - 2049-9450

DOI - 10.3892/mco.2021.2453

Subject(s) - precision medicine , cancer medicine , clinical trial , personalized medicine , medicine , profiling (computer programming) , cancer , oncology , bioinformatics , cost effectiveness , clinical practice , targeted therapy , intensive care medicine , computational biology , risk analysis (engineering) , computer science , biology , pathology , operating system , family medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research